Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

NCT02058901 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT02058901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
June 30, 2019
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors